Literature DB >> 22144688

Effect of antiplatelet agents, statins, and other drugs on vascular access patency rates.

Kosmas I Paraskevas, Dimitri P Mikhailidis, Nikolaos Roussas, Athanasios D Giannoukas.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22144688     DOI： 10.1177/0003319711414177

Source DB:  PubMed          Journal:  Angiology        ISSN： 0003-3197            Impact factor:   3.619


× No keyword cloud information.
  3 in total

1.  Role of antiplatelet therapy in the durability of hemodialysis access.

Authors:  Satinderjit Locham; Robert J Beaulieu; Hanaa Dakour-Aridi; Besma Nejim; Mahmoud B Malas
Journal:  J Nephrol       Date:  2018-05-05       Impact factor: 3.902

2.  The effect of lowering LDL cholesterol on vascular access patency: post hoc analysis of the Study of Heart and Renal Protection.

Authors:  William Herrington; Jonathan Emberson; Natalie Staplin; Lisa Blackwell; Bengt Fellström; Robert Walker; Adeera Levin; Lai Seong Hooi; Ziad A Massy; Vladimir Tesar; Christina Reith; Richard Haynes; Colin Baigent; Martin J Landray
Journal:  Clin J Am Soc Nephrol       Date:  2014-03-13       Impact factor: 8.237

3.  Antiplatelet agents maintain arteriovenous fistula and graft function in patients receiving hemodialysis: A nationwide case-control study.

Authors:  Yung-Ho Hsu; Yu-Chun Yen; Yi-Chun Lin; Li-Chin Sung
Journal:  PLoS One       Date:  2018-10-18       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.